Hukkelhoven Mathias
SEC insider (Form 3/4/5 filer). CIK 0001936319. Director at COMPUGEN LTD (CGEN) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2026. Located in HOLON.
Companies Hukkelhoven Mathias has filed insider reports for
- COMPUGEN LTD (CGEN): Director
- Centessa Pharmaceuticals plc (CNTA): Director
Hukkelhoven Mathias
CIK: 0001936319
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 29, 2026CGEN
COMPUGEN LTD
AwardDirect7.5K shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionDirectShare Option (right to buy)
96K shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionDirectShare Option (right to buy)
48K shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionDirectShare Option (right to buy)
48K shares- - Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionDirectShare Option (right to buy)
40K shares- - Jun 20, 2025CNTA
Centessa Pharmaceuticals plc
AwardDirectShare Option (right to buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 |  CGEN COMPUGEN LTD | Award | 7,500 | - | $0 | Direct |
| Jun 24, 2026 |  CNTA Centessa Pharmaceuticals plc | Disposition Share Option (right to buy) | 96,000 | - | - | Direct |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition Share Option (right to buy) | 48,000 | - | - | Direct |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition Share Option (right to buy) | 48,000 | - | - | Direct |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Disposition Share Option (right to buy) | 40,000 | - | - | Direct |
| Jun 20, 2025 | CNTA Centessa Pharmaceuticals plc | Award Share Option (right to buy) | 40,000 | - | - | Direct |
1-6 of 6 transactions